These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L, NASPEAF Investigators. J Am Coll Cardiol; 2004 Oct 19; 44(8):1557-66. PubMed ID: 15489085 [Abstract] [Full Text] [Related]
5. Atrial fibrillation and stroke risk prevention in real-life clinical practice. Tay KH, Lip GY, Lane DA. Thromb Haemost; 2009 Mar 19; 101(3):415-6. PubMed ID: 19277398 [No Abstract] [Full Text] [Related]
6. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators. J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454 [Abstract] [Full Text] [Related]
7. Oral anticoagulant treatment with and without aspirin. Altman R, Rouvier J, Gurfinkel E. Thromb Haemost; 1995 Jul 27; 74(1):506-10. PubMed ID: 8578514 [Abstract] [Full Text] [Related]
8. Stroke prevention in atrial fibrillation--pharmacologic strategies. Tiyyagura SR, Goldbarg SH, Mehta D. Indian Heart J; 2007 Jul 27; 59(4):311-5. PubMed ID: 19126935 [Abstract] [Full Text] [Related]
14. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators. Circulation; 2008 Nov 11; 118(20):2029-37. PubMed ID: 18955670 [Abstract] [Full Text] [Related]
15. Dual antiplatelet therapy is not optimal for stroke prevention in patients with atrial fibrillation. Chamorro A. Int J Stroke; 2010 Feb 11; 5(1):28-9. PubMed ID: 20088990 [Abstract] [Full Text] [Related]
16. Atrial fibrillation and anticoagulation. Garnier LF, Rouesnel P, Espitalier F. Arch Mal Coeur Vaiss; 2004 Oct 11; 97(10):1001-5. PubMed ID: 16008178 [Abstract] [Full Text] [Related]
17. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update]. Pengo V, De Caterina R. Ital Heart J Suppl; 2001 Sep 11; 2(9):972-9. PubMed ID: 11675834 [Abstract] [Full Text] [Related]
18. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials. Paikin JS, Wright DS, Eikelboom JW. Blood Rev; 2011 May 11; 25(3):123-9. PubMed ID: 21354678 [Abstract] [Full Text] [Related]
20. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ. Curr Med Res Opin; 2007 Jun 11; 23(6):1453-62. PubMed ID: 17559741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]